NextCell Pharma AB's total assets for Q4 2025 were kr76.73M, a decrease of ― from the previous quarter. SE:NXTCL total liabilities were kr10.34M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.